KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Change in Accured Expenses (2018 - 2026)

Castle Biosciences' Change in Accured Expenses history spans 8 years, with the latest figure at $3.8 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 49.38% to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.7 million, a 58.78% increase, with the full-year FY2025 number at $5.7 million, up 58.78% from a year prior.
  • Change in Accured Expenses hit $3.8 million in Q4 2025 for Castle Biosciences, down from $9.5 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for CSTL hit a ceiling of $9.5 million in Q3 2025 and a floor of -$11.6 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged $1.4 million across 5 years, with a median of $3.3 million in 2021.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 272.79% in 2024 and later skyrocketed 1463.01% in 2025.
  • Tracing CSTL's Change in Accured Expenses over 5 years: stood at $3.2 million in 2021, then surged by 51.0% to $4.8 million in 2022, then soared by 35.52% to $6.5 million in 2023, then plummeted by 60.8% to $2.6 million in 2024, then soared by 49.38% to $3.8 million in 2025.
  • Business Quant data shows Change in Accured Expenses for CSTL at $3.8 million in Q4 2025, $9.5 million in Q3 2025, and -$8.7 million in Q2 2025.